Koga et al., 2012 - Google Patents
Calcium/calmodulin-dependent protein kinase IV suppresses IL-2 production and regulatory T cell activity in lupusKoga et al., 2012
View HTML- Document ID
- 3705168183855513006
- Author
- Koga T
- Ichinose K
- Mizui M
- Crispín J
- Tsokos G
- Publication year
- Publication venue
- The Journal of Immunology
External Links
Snippet
The activity of calcium/calmodulin-dependent protein kinase IV (CaMK4) is increased in T cells from patients with systemic lupus erythematosus (SLE) and has been shown to reduce IL-2 production by promoting the effect of the transcriptional repressor cAMP responsive …
- 101700011792 CAMK4 0 title abstract description 63
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Koga et al. | Calcium/calmodulin-dependent protein kinase IV suppresses IL-2 production and regulatory T cell activity in lupus | |
Mishra et al. | TGF-β and Eomes control the homeostasis of CD8+ regulatory T cells | |
Yao et al. | Tr1 cells, but not Foxp3+ regulatory T cells, suppress NLRP3 inflammasome activation via an IL-10–dependent mechanism | |
Mackay et al. | T-box transcription factors combine with the cytokines TGF-β and IL-15 to control tissue-resident memory T cell fate | |
Takatori et al. | Lymphoid tissue inducer–like cells are an innate source of IL-17 and IL-22 | |
Sugawara et al. | Small intestinal eosinophils regulate Th17 cells by producing IL-1 receptor antagonist | |
Zhu et al. | The transcription factor T-bet is induced by multiple pathways and prevents an endogenous Th2 cell program during Th1 cell responses | |
Diveu et al. | IL-27 blocks RORc expression to inhibit lineage commitment of Th17 cells | |
Lochner et al. | In vivo equilibrium of proinflammatory IL-17+ and regulatory IL-10+ Foxp3+ RORγt+ T cells | |
Martinet et al. | Type I interferons regulate eomesodermin expression and the development of unconventional memory CD8+ T cells | |
Lind et al. | Micro-RNA 155 is required for optimal CD8+ T cell responses to acute viral and intracellular bacterial challenges | |
Auderset et al. | Notch signaling regulates follicular helper T cell differentiation | |
Morita et al. | Egr2 and Egr3 in regulatory T cells cooperatively control systemic autoimmunity through Ltbp3-mediated TGF-β3 production | |
Sestero et al. | CD5-dependent CK2 activation pathway regulates threshold for T cell anergy | |
Lee et al. | The influence of T cell Ig mucin-3 signaling on central nervous system autoimmune disease is determined by the effector function of the pathogenic T cells | |
Arbelaez et al. | IL-7/IL-7 receptor signaling differentially affects effector CD4+ T cell subsets involved in experimental autoimmune encephalomyelitis | |
Kim et al. | The requirements for natural Th17 cell development are distinct from those of conventional Th17 cells | |
Sriskantharajah et al. | Regulation of experimental autoimmune encephalomyelitis by TPL-2 kinase | |
Takatori et al. | Stat5a inhibits IL-12-induced Th1 cell differentiation through the induction of suppressor of cytokine signaling 3 expression | |
Zhou et al. | GARP–TGF-β Complexes Negatively Regulate Regulatory T Cell Development and Maintenance of Peripheral CD4+ T Cells In Vivo | |
Satoh et al. | The development of IL‐17/IFN‐γ‐double producing CTL s from T c17 cells is driven by epigenetic suppression of S ocs3 gene promoter | |
Nguyen et al. | IL-21 promotes lupus-like disease in chronic graft-versus-host disease through both CD4 T cell-and B cell-intrinsic mechanisms | |
Alahgholi-Hajibehzad et al. | The role of T regulatory cells in immunopathogenesis of myasthenia gravis: implications for therapeutics | |
Gurram et al. | Crosstalk between ILC2s and Th2 cells varies among mouse models | |
Yang et al. | NKG2D+ CD4+ T cells kill regulatory T cells in a NKG2D-NKG2D ligand-dependent manner in systemic lupus erythematosus |